Skip to content

Usability of the PreView PHP for Home Use in Intermediate AMD Patients

Usability of the PreView PHP for Home Use in Intermediate Age Related Macular Degeneration Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00776451
Enrollment
66
Registered
2008-10-21
Start date
2008-11-30
Completion date
2009-03-31
Last updated
2009-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration

Keywords

AMD

Brief summary

To demonstrate the ability of intermediate AMD subjects to follow the instructions for use and properly operate on their own the Preview PHP in home use environment, after going through training session.

Detailed description

The study purpose is to demonstrate that the target population can use the system after going through a supervised training session. The PreView PHP will be operated in the same manner in the simulated setting as it will be in future home use.

Interventions

None listed

Sponsors

Notal Vision Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Capable and willing to sign a consent form and participate in the study Subjects diagnosed as intermediate AMD in at least one eye * Age ≥65 years * VA with habitual correction better than 20/60 in the study eye * Ability to speak, read and understand instructions in English or Hebrew * Qualified to use the device by health care professional

Exclusion criteria

* Evidence of macular disease other than AMD or glaucoma in the study eye * Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP. * Any non-macular related ocular surgery or macular surgery performed within 3 months prior to study entry in the target eye * Participation in another study with the exclusion of AREDS study * Patients diagnosed with geographic atrophy (GA)

Design outcomes

Primary

MeasureTime frame
The proportion of subjects who successfully completed the test by themselves, in a home simulated environment2 clinic visits

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026